Evidence map›Paper›PMID 34504617›Full record

ArticleExperimental and therapeutic medicine2021

MicroRNA-124-5p delays the progression of cerebral aneurysm by regulating FoxO1.

Ru-Ke Wang, Yuan-Yuan Sun, Guang-You Li, Hua-Tang Yang, Xiu-Jie Liu, Ke-Feng Li, Xu Zhu, Guo-Yuan Yu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Epigenetic mechanisms in aneurysm formation, growth, and rupture: A systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ru-Ke WangSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Yuan-Yuan SunCT Room, Handan First Hospital, Handan, Hebei 056002, P.R. China.
Guang-You LiSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Hua-Tang YangSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Xiu-Jie LiuSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Ke-Feng LiSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Xu ZhuSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Guo-Yuan YuSection 2, Department of Neurosurgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Handan College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral aneurysm (CA) is a common brain disease, and the development of cerebral aneurysm is driven by inflammation and hemodynamic stress. MicroRNA (miR)-124-5p is reported to be associated with inflammatory response in brain disease such as cerebral ischemia-reperfusion injury. However, the function and molecular mechanism of miR-124-5p in CA are not clear, thus, the effects of miR-124-5p on inflammatory response in CA were explored. Firstly, the expression of miR-124-5p in the peripheral blood of patients with CA and the control group was detected by reverse transcription-quantitative PCR. Then, the human umbilical vein endothelial cells (HUVECs) were used as an

Indexed as

cerebral aneurysmFoxO1interleukin-1βmicroRNA-124-5p

Identifiers

PMID34504617
PMCPMC8393823
OpenAlexW3193929428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.